Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Insulet Corp PODD

Healthcare Medical Devices
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also... see more

Recent & Breaking News (NDAQ:PODD)

Insulet Announces Board Appointment of Elizabeth Weatherman and Retirement of David Lemoine

Business Wire February 7, 2022

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control

Business Wire January 28, 2022

Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2021

Business Wire January 12, 2022

Dr. Jessica Hopfield Appointed to Berkeley Lights Board of Directors

GlobeNewswire December 20, 2021

Insulet to Present at Nasdaq's 45th Investor Conference

Business Wire November 24, 2021

Insulet Reports Third Quarter 2021 Revenue Increase of 18% Year-Over-Year

Business Wire November 4, 2021

Insulet Honors Diabetes Awareness with Global Activities and Events

Business Wire November 1, 2021

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Business Wire October 18, 2021

Insulet's Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use

Business Wire September 30, 2021

Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021

Business Wire September 29, 2021

Insulet to Present at Upcoming Investor Conferences

Business Wire August 26, 2021

Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States

Business Wire August 16, 2021

Insulet Corporation to Announce Third Quarter 2017 Financial Results on November 2, 2017

Business Wire October 2, 2017

Insulet Breaks Ground on New U.S. Manufacturing Facility

Business Wire September 28, 2017

Insulet Corporation présente des données cliniques issues du monde réel sur l’utilisation de son système de gestion de l'insuline Omnipod® chez environ 39 000 patients utilisant un système de gestion des données basé sur le Cloud

Business Wire September 13, 2017

Insulet Corporation Presents Real-World Clinical Data on the Use of Its Omnipod® Insulin Management System in Approximately 39,000 Patients Using a Cloud-Based Data Management System

Business Wire September 13, 2017

Daily Technical Summary Reports on Medical Supplies Stocks -- Insulet, Microbot Medical, C.R. Bard, and Hill Rom

PR Newswire September 7, 2017

Healthcare Stock Performance Review -- Endologix, Zimmer Biomet, Insulet, and C.R. Bard

PR Newswire August 4, 2017

Insulet Reports Second Quarter 2017 Financial Results

Business Wire August 3, 2017

Investor Network: Insulet Corporation to Host Earnings Call

Accesswire August 3, 2017